Announced
Financials
Sources
Tags
Majority
Merger
Single Bidder
Pharmaceuticals
Public
cell therapy
South Korea
pharmaceuticals
Domestic
Acquisition
Friendly
Pending
Synopsis
GC LabCell, a biotechnology company, to merge with GC Cell, a company specializing in cell therapy. Under the terms of merger agreement, each share of GC Cell stock will be exchanged for a fixed ratio of 0.4 shares of GC LabCell stock. “The new co. will have a nearly ideal blend of business portfolios in the competitive field of cell therapy. Our similar cultures and histories of driving innovation in order to bring more effective and safer therapies to as many patients as possible make this integration a perfect strategic fit,” GC Cell.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.